Bausch Health Companies Inc. (BHC) Stock Price Increases Today

The stock of Bausch Health Companies Inc. (NYSE:BHC) is a huge mover today! The stock increased 4.03% or $1.03 during the last trading session, reaching $26.52. About 5.34 million shares traded or 26.90% up from the average. Bausch Health Companies Inc. (NYSE:BHC) has risen 58.45% since May 8, 2018 and is uptrending. It has outperformed by 54.08% the S&P500.
The move comes after 9 months positive chart setup for the $9.31 billion company. It was reported on May, 8 by Barchart.com. We have $28.38 PT which if reached, will make NYSE:BHC worth $651.49M more.

Analysts await Bausch Health Companies Inc. (NYSE:BHC) to report earnings on August, 6. They expect $1.03 EPS, up 10.75 % or $0.10 from last year’s $0.93 per share. BHC’s profit will be $361.47 million for 6.44 P/E if the $1.03 EPS becomes a reality. After $1.03 actual EPS reported by Bausch Health Companies Inc. for the previous quarter, Wall Street now forecasts 0.00 % EPS growth.

Bausch Health Companies Inc. (NYSE:BHC) Ratings Coverage

Among 2 analysts covering Bausch Health Companies (NYSE:BHC), 1 have Buy rating, 1 Sell and 0 Hold. Therefore 50% are positive. Bausch Health Companies had 2 analyst reports since March 20, 2019 according to SRatingsIntel. The firm has “Underperform” rating given on Wednesday, March 20 by Bank of America.

More notable recent Bausch Health Companies Inc. (NYSE:BHC) news were published by: Seekingalpha.com which released: “Bausch Health Companies: Careful For Now – Seeking Alpha” on November 23, 2018, also Seekingalpha.com with their article: “Bausch Health Companies: Shareholder Dilution Happening? – Seeking Alpha” published on November 08, 2018, Seekingalpha.com published: “Akorn up 17% premarket after recent FDA approvals – Seeking Alpha” on April 22, 2019. More interesting news about Bausch Health Companies Inc. (NYSE:BHC) were released by: Seekingalpha.com and their article: “Bausch Health Companies – The Little Engine That Could – Seeking Alpha” published on February 19, 2019 as well as Seekingalpha.com‘s news article titled: “Bausch Health: Headed Higher – Bausch Health Companies Inc. (NYSE:BHC) – Seeking Alpha” with publication date: May 08, 2019.

Bausch Health Companies Inc. develops, makes, and markets a range of pharmaceutical, medical device, and over-the-counter products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company has market cap of $9.31 billion. It offers dermatology products that treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis, cold sores, athlete's foot, nail fungus, and other dermatoses, as well as provides aesthetic medical devices, which address various conditions, including facial wrinkles, acne, pigmentation conditions, body sculpting, skin tightening, and laser hair removal. It currently has negative earnings. The firm also develops and markets products that treat gastrointestinal and hepatologic conditions comprising hepatic encephalopathy, irritable bowel syndrome with diarrhea, traveler's diarrhea, opioid-induced constipation, ulcerative colitis, and others.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.